Distinct disease mechanisms may underlie cognitive decline related to hearing loss in different age groups

J Neurol Neurosurg Psychiatry. 2023 Apr;94(4):314-320. doi: 10.1136/jnnp-2022-329726. Epub 2023 Jan 13.

Abstract

Background: Hearing loss in older adults is associated with increased dementia risk. Underlying mechanisms that connect hearing loss with dementia remain largely unclear.

Methods: We studied the association of hearing loss and biomarkers for dementia risk in two age groups with normal cognition: 65 participants from the European Medical Information Framework (EMIF)-Alzheimer's disease (AD) 90+ study (oldest-old; mean age 92.7 years, 56.9% female) and 60 participants from the EMIF-AD PreclinAD study (younger-old; mean age 74.4, 43.3% female). Hearing function was tested by the 'digits-in-noise test' and cognition by repeated neuropsychological evaluation. Regressions and generalised estimating equations were used to test the association of hearing function and PET-derived amyloid burden, and linear mixed models were used to test the association of hearing function and cognitive decline. In the oldest-old group, mediation analyses were performed to study whether cognitive decline is mediated through regional brain atrophy.

Results: In oldest-old individuals, hearing function was not associated with amyloid pathology (p=0.7), whereas in the younger-old individuals hearing loss was associated with higher amyloid burden (p=0.0034). In oldest-old individuals, poorer hearing was associated with a steeper decline in memory, global cognition and language, and in the younger-old with steeper decline in language only. The hippocampus and nucleus accumbens mediated the effects of hearing loss on memory and global cognition in the oldest-old individuals.

Conclusions: Hearing loss was associated with amyloid binding in younger-old individuals only, and with cognitive decline in both age groups. These results suggest that mechanisms linking hearing loss with risk for dementia depends on age.

Keywords: ALZHEIMER'S DISEASE; AMYLOID; COGNITION; DEMENTIA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease* / pathology
  • Amyloid beta-Peptides / metabolism
  • Cognition
  • Cognitive Dysfunction* / pathology
  • Female
  • Hearing Loss* / complications
  • Hearing Loss* / epidemiology
  • Humans
  • Male
  • Neuropsychological Tests

Substances

  • Amyloid beta-Peptides